← Leaderboards
Pengda Liu
Univ Of North Carolina Chapel Hill
$3,650,940
Attributed
$4,160,890
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $647.9K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,160,890 · 6
By mechanism
R01$2,401,498 · 2
R21$767,502 · 2
R00$652,554 · 1
K99$339,336 · 1
Top collaborators
- Ian J Davis2 shared
- Qi Zhang1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Ian J Davis$7,130,869
- Teresa Kathleen Tarrant$745,145
- Justin Ethan Wilson$1,144,784
- Guochun Jiang$3,804,073
- Ph.d, Jeffrey Frelinger$356,696
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsNeoplasm MetastasisMolecularInsightIn VitroSignal TransductionMediatingXenograft ProcedureTumorigenesisMouse ModelIn VivoComplexPlayTailPathway InteractionsNovel TherapeuticsPhenotypeBindingOncogenicGenesPhosphorylationGrowthEventChromatin
Grant awards (15)
Epigenetic Regulation of Nuclear cGAS Activity in Aging-Related Inflammation$647,866
R01 · FY2025 · AG
Elucidating novel functions of cGAS in breast cancer$337,922
R01 · FY2024 · CA · contact PI
Elucidating novel functions of cGAS in breast cancer$348,592
R01 · FY2023 · CA · contact PI
Cancer Hijacks Enzyme Substrate Mutations to Facilitate Tumorigenesis$213,727
R21 · FY2023 · CA · contact PI
Elucidating novel functions of cGAS in breast cancer$355,706
R01 · FY2022 · CA · contact PI
Cancer Hijacks Enzyme Substrate Mutations to Facilitate Tumorigenesis$181,741
R21 · FY2022 · CA · contact PI
Elucidating novel functions of cGAS in breast cancer$355,706
R01 · FY2021 · CA · contact PI
Elucidating novel functions of cGAS in breast cancer$355,706
R01 · FY2020 · CA · contact PI
Targeting EWS-FLI1 protein stability as therapeutic strategy for Ewing sarcoma$202,928
R21 · FY2020 · CA · contact PI
Targeting EWS-FLI1 protein stability as therapeutic strategy for Ewing sarcoma$169,106
R21 · FY2019 · CA · contact PI
Elucidating a Novel Akt Activation Mechanism for Targeted Prostate Cancer Therapy$217,518
R00 · FY2018 · CA · contact PI
Elucidating a Novel Akt Activation Mechanism for Targeted Prostate Cancer Therapy$217,518
R00 · FY2017 · CA · contact PI
Elucidating a Novel Akt Activation Mechanism for Targeted Prostate Cancer Therapy$217,518
R00 · FY2016 · CA · contact PI
Elucidating a Novel Akt Activation Mechanism for Targeted Prostate Cancer Therapy$169,668
K99 · FY2015 · CA · contact PI
Elucidating a Novel Akt Activation Mechanism for Targeted Prostate Cancer Therapy$169,668
K99 · FY2014 · CA · contact PI